Key Features:

• Purpose-Built for Large Proximal Vessels: Specifically engineered to tackle the complexities of large vessel anatomies, including critical areas such as the left main, bifurcations, and ostial lesions.
• SYNERGY Bioabsorbable Polymer (BP) Technology: Designed to promote early healing while ensuring freedom from long-term polymer exposure. This innovative technology significantly reduces inflammation rates, enhancing patient comfort and recovery.
• Early Healing Benefits: The SYNERGY MEGATRON stent’s unique formulation and design support rapid healing of the treated vessel, which contributes to improved long-term outcomes for patients.

Bench Test Results: The SYNERGY MEGATRON stent has demonstrated exceptional performance in bench tests, showcasing its best-in-class axial and radial strength. These tests confirm the stent’s ability to withstand the rigors of large vessel interventions, providing unmatched support and reliability.

Samant S, Wu W, Zhao S, Khan B, Sharzehee M, Panagopoulos A, Makadia J, Mickley T, Bicek A, Boismier D, Murasato Y, Chatzizisis YS. Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions. Sci Rep. 2021 Apr 22;11(1):8728. doi: 10.1038/s41598-021-87908-2. PMID: 33888765; PMCID: PMC8062511.